Finance

Lists
Why is 002275 down 3.15%?
Dive Deeper
002275:SHE
Guilin Sanjin Pharmaceutical Co., Ltd.
CNยฅ12.92
-3.15%
(-0.42) 1D
Nov 17, 3:04:42โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002275...
Open
CNยฅ13.22
High
CNยฅ13.47
Low
CNยฅ12.86
Mkt. cap
7.84B
Avg. vol.
21.10M
Volume
27.18M
Dividend
3.48%
Quarterly dividend
CNยฅ0.11
Ex-dividend date
Nov 11, 2026
P/E ratio
17.98
52-wk high
CNยฅ19.32
52-wk low
CNยฅ11.82
EPS
CNยฅ0.72
Shares outstanding
587.57M
No. of employees
3K
Open
CNยฅ13.22
High
CNยฅ13.47
Low
CNยฅ12.86
Mkt. cap
7.84B
Avg. vol.
21.10M
Volume
27.18M
Dividend
3.48%
Quarterly dividend
CNยฅ0.11
Ex-dividend date
Nov 11, 2026
P/E ratio
17.98
52-wk high
CNยฅ19.32
52-wk low
CNยฅ11.82
EPS
CNยฅ0.72
Shares outstanding
587.57M
No. of employees
3K
News stories
From web sources and news partners
About Guilin Sanjin Pharmaceutical Co., Ltd.
CEO-
Employees2.56K
FoundedFeb 23, 1994
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
583.35M
525.12M
443.48M
475.45M
Cost of goods sold
146.29M
93.13M
145.58M
117.25M
Cost of revenue
146.29M
93.13M
145.58M
117.25M
Research and development expenses
68.98M
53.24M
10.16M
16.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
270.13M
185.28M
122.37M
187.31M
Operating expense
354.02M
284.20M
152.34M
211.33M
Total operating expenses
500.30M
377.33M
297.92M
328.58M
Operating income
83.04M
147.79M
145.56M
146.87M
Other non operating income
1.46M
-151.83K
-496.00
-503.26K
EBT including unusual items
67.38M
152.08M
161.91M
136.60M
EBT excluding unusual items
74.31M
150.90M
149.82M
147.96M
Income tax expense
19.47M
27.73M
25.60M
22.92M
Effective tax rate
28.90%
18.23%
15.81%
16.78%
Other operating expenses
1.60M
1.07M
15.00M
7.57M
Net income
47.91M
124.36M
136.31M
113.68M
Net profit margin
8.21%
23.68%
30.74%
23.91%
Earnings per share
-
-
-
-
Interest and investment income
6.17M
4.23M
9.11M
3.74M
Interest expense
-16.71M
-971.70K
-4.93M
-2.06M
Net interest expenses
-10.54M
3.26M
4.18M
1.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
103.95M
168.69M
166.41M
167.78M
Gain or loss from assets sale
-145.62K
-
-8.06K
8.06K
Upcoming events
AI content may include mistakes. Learn more
Google apps